• SELECT SITE CURRENCY
Select a currency for use throughout the site
Analgesics in New Zealand
Euromonitor International, March 2012, Pages: 32
Analgesics current retail value growth of 1% in 2011 was lower than the review period average of 2%, partly as a result of decreasing acetaminophen sales. Acetaminophen accounted for 39% of analgesics current retail value sales in 2011. In addition to falling sales within acetaminophen, aspirin has also reached a very high level of maturity.
The Analgesics in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
ANALGESICS IN NEW ZEALAND
LIST OF CONTENTS AND TABLES
Summary 1 Switches 2010-2011
Table 1 Sales of Analgesics by Category: Value 2006-2011
Table 2 Sales of Analgesics by Category: % Value Growth 2006-2011
Table 3 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
Table 4 Analgesics Company Shares by Value 2007-2011
Table 5 Analgesics Brand Shares by Value 2008-2011
Table 6 Forecast Sales of Analgesics by Category: Value 2011-2016
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016
Consumer Health Remains Buoyant During 2011
Prevention Remains A Major Focus Area
Vitaco Health Continues To Lead Sales
Direct Selling Channel Records Growth in 2011
Value Sales Expected To Increase Over Forecast Period
Key Trends and Developments
New Zealand's Ageing Population
New Zealand To Be Smoke-free by 2025
Natural Health Products Bill
Natural Healing and Prevention
Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 9 Life Expectancy at Birth 2006-2011
Table 10 Sales of Consumer Health by Category: Value 2006-2011
Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 12 Consumer Health Company Shares 2007-2011
Table 13 Consumer Health Brand Shares 2008-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Summary 2 OTC - Switches 2009-2011
Summary 3 Research Sources